Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Julius M. Wilder"'
Autor:
Christine Park, Mandisa-Maia Jones, Samantha Kaplan, Felicitas L. Koller, Julius M. Wilder, L. Ebony Boulware, Lisa M. McElroy
Publikováno v:
International Journal for Equity in Health, Vol 21, Iss 1, Pp 1-20 (2022)
Abstract Background Organ transplant is the preferred treatment for end-stage organ disease, yet the majority of patients with end-stage organ disease are never placed on the transplant waiting list. Limited access to the transplant waiting list comb
Externí odkaz:
https://doaj.org/article/feaa8733ff4c4493b1fca3fade473628
Autor:
Jeremy Louissaint, Julius M. Wilder, Elliot B. Tapper, Jorge A. Rodriguez, Russell Rosenblatt, Elizabeth C. Verna
Publikováno v:
Clinical Gastroenterology and Hepatology. 21:1385-1389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6495c2657397a22bbdf4cc62e197ff1c
https://doi.org/10.1016/j.cgh.2022.11.042
https://doi.org/10.1016/j.cgh.2022.11.042
Autor:
Christopher D. Woodrell, Arpan A. Patel, Julius M. Wilder, Vinay Sundaram, Raymond T. Chung, Nneka N. Ufere
Publikováno v:
Clin Liver Dis (Hoboken)
Content available: Audio Recording.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44f617358a2550131203c53712c077e9
https://doi.org/10.1002/cld.1225
https://doi.org/10.1002/cld.1225
Publikováno v:
Liver Transplantation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc62511b8025cb9ea1bf025fe05925ab
https://doi.org/10.1097/lvt.0000000000000127
https://doi.org/10.1097/lvt.0000000000000127
Publikováno v:
Clinical Gastroenterology and Hepatology. 19:1516-1519
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6a1f34f603e9c128787e183b27e15e1
https://doi.org/10.1016/j.cgh.2021.04.024
https://doi.org/10.1016/j.cgh.2021.04.024
Autor:
Andrew Scott, Hannah Lee, Pratima Sharma, AnnMarie Liapakis, Russell Rosenblatt, Keri E Lunsford, Julius M. Wilder
Publikováno v:
Hepatology. 74:2808-2812
The COVID-19 pandemic and social justice movement have highlighted the impact of social determinants of health (SDOH) and structural racism in the United States on both access to care and patient outcomes. With the evaluation for liver transplantatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::316ffcc263ae74860b0648fe64874236
https://doi.org/10.1002/hep.31986
https://doi.org/10.1002/hep.31986
Publikováno v:
Hepatology (Baltimore, Md.)REFERENCES.
Telehealth may be a successful strategy to increase access to specialty care for liver disease, but whether the areas with low access to care and a high burden of liver-related mortality have the necessary technology access to support a video-based t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e75c0a8fe4317fec2b99a9e9ca5512b9
https://pubmed.ncbi.nlm.nih.gov/35661393
https://pubmed.ncbi.nlm.nih.gov/35661393
Autor:
Julius M. Wilder, Andrew J. Muir, Matthew R. Kappus, Yuval A. Patel, Andrew S. Barbas, Donna Niedzwiecki, Carl L. Berg, Cynthia A. Moylan, Jacqueline B. Henson
Publikováno v:
Transplantation. 104:e164-e173
Background Patients with nonalcoholic steatohepatitis (NASH) are waitlisted at older ages than individuals with other liver diseases, but the effect of age on liver transplantation (LT) outcomes in this population and whether it differs from other et
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c898f1a47da130c0e7fd66a6205a0f8b
https://doi.org/10.1097/tp.0000000000003219
https://doi.org/10.1097/tp.0000000000003219
Publikováno v:
Therapeutics and Clinical Risk Management. 15:1443-1451
Acute intermittent porphyria (AIP) is an autosomal dominant metabolic disorder characterized by a deficiency in heme biosynthesis. Heme biosynthesis occurs throughout the body, but it is most prominent in the erythroblastic system and liver. AIP is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92e044690421732034c14de83eae1c10
https://doi.org/10.2147/tcrm.s180161
https://doi.org/10.2147/tcrm.s180161
Autor:
Christine Park, Mandisa-Maia Jones, Samantha Kaplan, Felicitas L. Koller, Julius M. Wilder, L. Ebony Boulware, Lisa M. McElroy
Publikováno v:
International Journal for Equity in Health, Vol 21, Iss 1, Pp 1-20 (2022)
Background Organ transplant is the preferred treatment for end-stage organ disease, yet the majority of patients with end-stage organ disease are never placed on the transplant waiting list. Limited access to the transplant waiting list combined with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6fe77b5d741252e20b71d0628813e9a
https://pubmed.ncbi.nlm.nih.gov/35151327
https://pubmed.ncbi.nlm.nih.gov/35151327